Publications
265
Citations
18,430
Est. group size
—
Recurring co-author estimate
Active years
43
Publishing since 1983
John T. Kissel's research focuses on neuromuscular diseases, including muscular dystrophies, spinal muscular atrophy, myasthenia gravis, myositis, and peripheral nerve disorders such as neuropathies. Much of the work involves clinical trials and the development of outcome measures to assess symptoms, disease progression, and quality of life in patients with these conditions. This research aims to improve how clinicians measure disease severity and treatment response in rare neuromuscular disorders.
Publication output was higher and more consistent from 2017-2020 (11-24 papers/year) but has slowed considerably since 2021, averaging under 3 papers per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The Neuropathies of Vasculitis
Neurologic Clinics · 2025
- Remembering Dr. Julaine Florence, DPT
RRNMF Neuromuscular Journal · 2025
- Autonomic Neuropathies
Neurologic Clinics · 2025
- Database Evaluation for Muscle and Nerve Diseases - DEMAND: An academic neuromuscular coding system
RRNMF Neuromuscular Journal · 2023
- The Effects of Testosterone and Transcutaneous Muscle Stimulation on Strength and Muscle Mass in Myotonic Dystrophy
RRNMF Neuromuscular Journal · 2023
- The Facioscapulohumeral Muscular <scp>Dystrophy‐Health</scp> Index: Development and evaluation of a <scp>disease‐specific</scp> outcome measure
Muscle & Nerve · 2023
- The Spinal Muscular Atrophy Health Index: A novel outcome for measuring how a patient feels and functions
Muscle & Nerve · 2021
- Quantifying Treatment-Related Fluctuations in CIDP
Neurology · 2021
- A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
UNC Libraries · 2020
- Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Muscle & Nerve · 2019
- Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
The Lancet Neurology · 2019
- A placebo-controlled study to evaluate the safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy
2018
- Disease progression in Myotonic Dystrophy Type 1 during a non-interventional multicenter study (S22.004)
Neurology · 2018
- Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA)
Neurology · 2018
- An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members
Journal of Neuromuscular Diseases · 2018
- Neurology×35
- Muscle & Nerve×14
- Elsevier eBooks×8
- The Lancet Neurology×6
- Journal of Neuromuscular Diseases×4
- Jerry R. Mendell
Medicine · The Ohio State University
- W. David Arnold
Medicine · The Ohio State University
- Megan A. Waldrop
Medicine · The Ohio State University
- Alayne P. Meyer
Medicine · The Ohio State University
- Arthur H.M. Burghes
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile